Clinical Trial Update: Neuronostatin - a Glucagonotropic Agent in Humans? [NA]

View source ↗

Summary

A clinical trial update indicating that the study of Neuronostatin, a glucagonotropic agent, has completed at University Hospital, Gentofte, Copenhagen, for Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Neuronostatin (Neuronostatin)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 1 Diabetes, Hypoglycemia | NA | Status: COMPLETED